← The SEC Ephemeris: the whole map
Agile Therapeutics, Inc. levonorgestrel/ethinyl estradiol
In the graph: all 3 documents (11 pages).
- Application
- NDA 204017
- Ticker
- Agile Therapeutics, Inc.
- Product
- levonorgestrel/ethinyl estradiol
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- December 21, 2017 · July 17, 2013 · February 13, 2013
From FDA letters and SEC filings. Not investment or medical advice.